Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer's-like neuropathology

Nirjal Mainali1,2, Meenakshisundaram Balasubramaniam2, Sonu Pahal1,2

  • 1Bioinformatics Program, University of Arkansas for Medical Sciences and University of Arkansas at Little Rock, Little Rock, AR, 72205, USA.

PubMed

Insights

Myocardial infarction (MI) in mice and cardiovascular disease (CVD) patients show shared protein aggregation and endoplasmic reticulum (ER) stress, linking heart issues to neurodegeneration risk.

Area of Science:

  • Neurobiology
  • Cardiology
  • Proteomics

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of death.
  • CVDs are linked to increased neurodegeneration risk, but underlying mechanisms remain unclear.
  • Previous studies showed myocardial infarction (MI) induces protein aggregation and ER stress in the heart and brain.

Purpose of the Study:

  • Investigate molecular mechanisms linking MI and neurodegeneration.
  • Compare molecular changes in MI mouse models with human Alzheimer's disease (AD) and CVD patient aggregates.
  • Identify key proteins and pathways altered by MI and implicated in neurodegeneration.

Main Methods:

  • Induced MI in mice and compared to sham-MI controls.
  • Proteomic analysis of human hippocampal aggregates from AD, CVD patients, and age-matched controls (AMC).
  • Intra-aggregate crosslinking to map protein-protein interactions ('contactomes').
  • Leave-one-out analysis (LOOA) to assess protein contribution to aggregate cohesion.
  • Gene ontology meta-analyses to identify critical pathways.

Main Results:

  • Identified influential proteins in both AD and CVD aggregates.
  • Found shared pathways implicated in neurodegeneration, including mitochondrial dysfunction, oxidative stress, ER stress, protein aggregation, and impaired proteostasis (ubiquitin-proteasome system, autophagy).
  • Highlighted alterations in axonal transport and synaptic function.

Conclusions:

  • MI induces molecular changes in the brain that overlap with those found in human neurodegenerative diseases like AD.
  • Protein aggregation and ER stress are key shared mechanisms linking cardiovascular health and brain integrity.
  • Findings provide insights into the molecular basis of CVD-associated neurodegeneration.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
40
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69